Skip to main content

The Third Annual Hastings Center Cunniff-Dixon Physician Award

The 2012 recipients of the third annual Hastings Center Cunniff-Dixon Physician Awards were just recently announced. I was honored to be one of the recipients of this award last year, but am humbled by this year’s awardees. Richard Payne said it best in the Hastings Center press release: "This year's winners emerged from an exceptionally strong field of nominees and serve as models of competent, caring, compassionate doctoring."

The awardees for the 2012 year are:

Senior Physician Award: 

  • Janet Bull, MD.  Janet is the chief medical director and principal investigator of Four Seasons, a nonprofit hospice and palliative care organization in North Carolina. She is a role model for many palliative care clinicians thanks to her work that combines both clinical practice, research, and local and national leadership in hospice and palliative care. 

Mid-Career Award: 

  • Michael Rabow, MD.  Mike is a professor of clinical medicine at the University of California San Francisco (UCSF). In addition to being one of the nicest palliative care doctors I have ever met, Mike is one of the true visionaries in palliative care. Among his numerous accomplishments, Mike developed one of the first outpatient palliative care clinics in the US, the Symptom Management Service at UCSF Hellen Diller Family Comprehensive Cancer Care Center. 

Early-career Awards: 

  • Justin N. Baker, MD. Justin directs the Division of Palliative and End-of-Life Care and the Hematology/Oncology Fellowship Program at St. Jude Children's Research Hospital. He was recognized for his outstanding leadership and research in pediatric palliative care.
  • Jason Morrow, MD, PhD. Jason is the Medical Director of inpatient palliative care at the University of Texas Health Science Center at San Antonio. Jason was recognized “for his advocacy in expanding palliative care services and his passion for educating medical students, residents, and other physicians in clinical practices and ethics.” 
  • Theresa A. Soriano, MD, MPH. Theresa runs the Mount Sinai Visiting Doctors Program at Mount Sinai School of Medicine in New York. She is being recognized in part for her advocacy and leadership in caring for underserved patients and bringing primary and palliative care to those who are homebound. 

A very big congratulations to all the awardees.  Thank you for all your hard work.

by: Eric Widera

Comments

Popular posts from this blog

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Language Matters: Podcast with Brian Block and Anna DeForest

One of our first GeriPal posts was titled "Rant on Terminology," by Patrice Villars, NP.  In the spirit of looking back over our first 10 years, here is the opening paragraph to that post:

News Headlines read: Sen. Edward Kennedy loses battle with cancer. Really, he lost? I thought he died from a malignant brain tumor, an “aggressive” brain tumor. The median survival is less than a year for people for his particular tumor. Kennedy was diagnosed in May of 2008. He lived over 15 months after diagnosis. What a loser. He must not have fought hard enough. Huh? I thought he spent most of his life battling for social and health care reform in America. In this week's GeriPal podcast we take a deeper dive into this issue of language and medicine.  We are joined by guests Anna DeForest, MD, MFA, a resident in Neurology at Yale, and Brian Block, MD, a pulmonary critical care fellow at UCSF.  

Anna recently published a paper in the NEJM describing her reaction to hearing terms like, &…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …